"Dr Reddy"
Latest news and video coverage curated from trusted media outlets
You Might Like
Pharma faces USFDA heat, stocks downThe stocks of several pharma companies, including Dr Reddy's, Aurobindo Pharma, Cipla, Lupin, Sun Pharma, and Divi's Labs, have been lagging behind as the sensex and Nifty reach new highs. Dr Reddy's..IndiaTimes - Published | |
Dr Reddy's inks pact with Coya Therapeutics for investigational ALS therapy COYA 302Dr Reddy's Laboratories SA, a subsidiary of Dr Reddy's Laboratories, has signed a development and licence agreement with Coya Therapeutics Inc for the development and commercialisation of COYA 302, a..IndiaTimes - Published | |
Experts Urge for Preventive Lifestyle and Awareness on Treatment Options at the Osteoporosis Awareness SummitThe experts at the Osteoporosis Awareness Summit observed that osteoporosis is a public health emergency, however early screening and preventive lifestyle can help in proactive management and effective..NewsVoir - Published | |
Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observationsOn Thursday, Dr. Reddy's Laboratories, a prominent pharmaceutical company, disclosed to the stock exchanges that it has been issued a Form 483 containing nine observations by the US Food & Drug..IndiaTimes - Published | |
India: Delhi High Court Rules In Favour Of Reddy's Laboratories On Use Of The Mark RAZOFAST By Fast Cure Pharma - LexOrbisIn the recent case of Dr. Reddy's Laboratories Ltd vs Fast Cure Pharma, the plaintiff applied to the Delhi High Court for a permanent injunction restraining the defendant from manufacturing...Mondaq - Published | |
Net Worth: Rs 20,0000 Crore, Age - 91, Goes To Office 6 Days A Week - Pratap Reddy's Incredible StoryThis article delves into Dr. Reddy's remarkable career, his dedication to the family's healthcare legacy, and his commitment to nurturing the succeeding generations of leaders.Zee News - Published | |
United States: § 112(a) Is A Priority In Decision To Institute IPR; Did Not Work To Say Petitioner Should Have Filed A PGR - Finnegan, Henderson, Farabow, Garrett & Dunner, LLPPetitioner Dr. Reddy's Laboratories challenged the patentability of several claims of U.S. Patent No. 11,110,087 ("the '087 patent") on 35 U.S.C. § 102 anticipation grounds. IPR2023-00052, Paper 7 at..Mondaq - Published | |
USFDA accepts Dr Reddy's rituximab biosimilar candidate DRL_RI for substantive reviewIndiaTimes - Published | |
Dr Reddy’s forays into child nutrition spaceIndiaTimes - Published | |
Dr Reddy's enters generics business in India marketIndiaTimes - Published | |
Aurobindo arm Eugia, Dr Reddy's & Hetero bag MPP sub-licence for generic leukemia drug NilotinibIndiaTimes - Published | |
Dr Reddy’s forays into non-branded generics in Indian market with RGenXIndiaTimes - Published | |
Meet MSN Reddy, from chemist to net worth Rs 11400 crore, left leading MNC to build...Among the richest people of Hyderabad, Dr Reddy is the founder and chairman of MSN Labs, one of the fastest growing pharma companies in India that he built from scratch.DNA - Published | |
